Vaccine used in Azerbaijan is effective against British strain - OFFICIAL
Health
- 18 March, 2021
- 09:02
Add Report.az to preferred Google sources
Stay up to date with the top news!
The CoronoVAC vaccine produced by the Chinese company SinoVac, which is used against coronavirus infection in Azerbaijan, is also effective against new strains, the National Center for Hematology and Transfusion told Report.
501Y.V1 and B.1.1.7 (British version) were found in three samples analyzed by the Sars Cov-2 genome at the Center's Genetic Diagnostic Center.
Azerbaijan started the vaccination process on January 18. Vaccination is performed voluntarily and at state expense. To date, 468,826 people in the country have been vaccinated.
Latest News
13:58
Vietnamese Vice President arrives in Azerbaijan for CICA Summit
Foreign policy
13:56
Photo
Media Council: Iran's Sahar Azəri spread disinformation by linking footage from Diyarbakır to Azerbaijan
Media
13:51
IEA: Azerbaijan fell 110,000 b/d short of OPEC+ quota in September
Energy
13:18
Deputy Minister: Reconstruction of Khankandi Stadium nearing completion
Infrastructure
13:17
Discover the World appointed to represent AZAL in Belgium and the Netherlands
Infrastructure
13:15
Nearly $650,000 to be invested in PPP projects in Azerbaijan
Business
13:10
Garabagh to host forum for Yukselish competition winners
Infrastructure
12:54
Special rep: Next resettlement to Kalbajar's Zar village expected soon
Infrastructure
12:41
Azerbaijan U23 beat UAE at Minifootball World Cup
Football